Cognitive Enhancers: Role of the Glutamate System

  • Living reference work entry
  • First Online:
Encyclopedia of Psychopharmacology
  • 163 Accesses

Synonyms

Nootropics

Definition

Cognitive enhancers are drugs that are used to treat problems of memory, attention, and inhibitory control.

Pharmacological Properties

Cognitive problems exist in a variety of psychiatric and neurological disorders. Current nootropics, the acetylcholinesterase inhibitors, are used primarily to treat Alzheimer’s disease. These drugs have limited efficacy and cannot be used ubiquitously across all disorders where cognitive enhancement might be beneficial (e.g., they are inappropriate for the use in patients with Parkinson’s disease as they can aggravate the motor disability). Therefore, the future development of a range of drugs with different mechanisms of action is likely to occur.

Ionotropic Glutamate Receptors

Ionotropic glutamate receptors as a target for cognition enhancement have been of interest since the 1980s following the discovery of their involvement in long-term potentiation (LTP; a persistent strengthening of synapses). This form of synaptic...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Black MD (2005) Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data. Psychopharmacology (Berl) 179:154–163

    Article  CAS  Google Scholar 

  • Cooke SF, Bliss TVP (2005) Long-term potentiation and cognitive drug discovery. Curr Opin Investig Drugs 6(1):25–34

    CAS  PubMed  Google Scholar 

  • Davis M, Ressler K, Rothbaum BO, Richardson R (2006) Effects of d-Cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry 60:369–375

    Article  CAS  PubMed  Google Scholar 

  • Kauer JA, Malenka RC (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8:844–858

    Article  CAS  PubMed  Google Scholar 

  • Lynch G (2004) AMPA-receptor modulators as cognitive enhancers. Curr Opin Pharmacol 4:4–11

    Article  CAS  PubMed  Google Scholar 

  • Millan MJ (2005) N-methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology (Berl) 179:30–53

    Article  CAS  Google Scholar 

  • O’Neill MJ, Dix S (2007) AMPA receptor potentiators as cognitive enhancers. IDrugs 10:185–192

    PubMed  Google Scholar 

  • Priestley T, Laughton P, Myers J, Le Bourdelles B, Kerby J, Whiting PJ (1995) Pharmacological properties of recombinant human N-methyl-d-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol Pharmacol 48:841–848

    CAS  PubMed  Google Scholar 

  • Robbins TW, Murphy ER (2006) Behavioural pharmacology: 40C years of progress, with a focus on glutamate receptors and cognition. TIPS 27:141–148

    CAS  PubMed Central  PubMed  Google Scholar 

  • Tang Y-P, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ (1999) Genetic enhancement of learning and memory in mice. Nature 401:63–69

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne Jackson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Jackson, A. (2014). Cognitive Enhancers: Role of the Glutamate System. In: Stolerman, I., Price, L. (eds) Encyclopedia of Psychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27772-6_170-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27772-6_170-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27772-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Navigation